companydata.dkVesper Bio ApS: Financial statements 2014
CVR: 32879861
Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -6,940,347 compared with DKK -2,554,127 the year before. Equity amounted to DKK 5,634,281. The solvency ratio was 90%.
- Profit/Loss
- -6,940,347 kr.
- Equity
- 5,634,281 kr.
- Total Assets
- 6,262,513 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | -6.9 mio. | 5.6 mio. | - |
| 2013 | - | - | -2.6 mio. | 12.6 mio. | - |
| 2012 | - | -22 t. | -16 t. | 377 t. | - |
Keep an eye on Vesper Bio ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
Vesper Bio ApS has published its annual report for 2013. The net result was DKK -2,554,127.
About Vesper Bio ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees. In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity amounted to DKK -227,433,239.